Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Jul 7, 2022

50715_rns_2022-07-07_f64661d4-7e09-486d-9bb9-05a151c9d62a.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

7 July 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Description Nature of dealings Purchase / Total Total amount Highest (H) Lowest (L)
of relevant Sale number paid / received prices paid prices paid
securities of shares / received / received
involved
China 6 July 2022 Other types Closing / flattening / unwinding of Sale 8,000 $158,640.0000 $19.8300 $19.8300
International of securities proprietary positions arising from
Capital (e.g. equity unsolicited client-driven dealings. I
Corporation swaps) confirm this was done no later than the
Limited close of the morning trading session
on the trading day following the
orginatingclient-driven dealing

==> picture [71 x 43] intentionally omitted <==

Public Disclosure Form

Other typesof securities(e.g. equityswaps) Closing / flattening / unwinding ofproprietary positions arising fromunsolicited client-driven dealings. Iconfirm this was done no later than theclose of the morning trading sessionon the trading day following theorginatingclient-driven dealing Purchase 8,000 $158,640.0000 $19.8300 $19.8300

End

Note:

China International Capital Corporation Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.